306 related articles for article (PubMed ID: 34884512)
1. C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease.
Magnusen AF; Rani R; McKay MA; Hatton SL; Nyamajenjere TC; Magnusen DNA; Köhl J; Grabowski GA; Pandey MK
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884512
[TBL] [Abstract][Full Text] [Related]
2. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
[TBL] [Abstract][Full Text] [Related]
3. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.
Pandey MK; Burrow TA; Rani R; Martin LJ; Witte D; Setchell KD; Mckay MA; Magnusen AF; Zhang W; Liou B; Köhl J; Grabowski GA
Nature; 2017 Mar; 543(7643):108-112. PubMed ID: 28225753
[TBL] [Abstract][Full Text] [Related]
4. Gaucher disease: chemotactic factors and immunological cell invasion in a mouse model.
Pandey MK; Jabre NA; Xu YH; Zhang W; Setchell KD; Grabowski GA
Mol Genet Metab; 2014 Feb; 111(2):163-71. PubMed ID: 24079945
[TBL] [Abstract][Full Text] [Related]
5. NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.
Wu X; Lahiri A; Haines GK; Flavell RA; Abraham C
J Immunol; 2014 Apr; 192(7):3409-18. PubMed ID: 24591373
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
7. Herpes Simplex Virus Type 2 Infection-Induced Expression of CXCR3 Ligands Promotes CD4
Zhang M; Deng X; Guan X; Geng L; Fu M; Zhang B; Chen R; Hu H; Hu K; Zhang D; Li M; Liu Y; Gong S; Hu Q
Front Immunol; 2018; 9():2932. PubMed ID: 30619292
[TBL] [Abstract][Full Text] [Related]
8. LINC00152 mediates CD8
Ou J; Lei P; Yang Z; Yang M; Luo L; Mo H; Luo G; He J
J Mol Histol; 2021 Jun; 52(3):611-620. PubMed ID: 33709190
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of Allergic Pulmonary Inflammation in CXCR3Knockout Mice Sensitized and Challenged with House Dust Mite Protein.
Liu Z; Chen H; Chen X; Gao J; Guo Z
PLoS One; 2016; 11(10):e0162905. PubMed ID: 27727269
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.
Campanella GS; Tager AM; El Khoury JK; Thomas SY; Abrazinski TA; Manice LA; Colvin RA; Luster AD
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4814-9. PubMed ID: 18347328
[TBL] [Abstract][Full Text] [Related]
11. The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis
Liu QZ; Ma WT; Yang JB; Zhao ZB; Yan K; Yao Y; Li L; Miao Q; Gershwin ME; Lian ZX
Front Immunol; 2018; 9():1090. PubMed ID: 29868034
[TBL] [Abstract][Full Text] [Related]
12. Exercise Training Improves Tumor Control by Increasing CD8
Gomes-Santos IL; Amoozgar Z; Kumar AS; Ho WW; Roh K; Talele NP; Curtis H; Kawaguchi K; Jain RK; Fukumura D
Cancer Immunol Res; 2021 Jul; 9(7):765-778. PubMed ID: 33839688
[TBL] [Abstract][Full Text] [Related]
13. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
Wasmuth HE; Lammert F; Zaldivar MM; Weiskirchen R; Hellerbrand C; Scholten D; Berres ML; Zimmermann H; Streetz KL; Tacke F; Hillebrandt S; Schmitz P; Keppeler H; Berg T; Dahl E; Gassler N; Friedman SL; Trautwein C
Gastroenterology; 2009 Jul; 137(1):309-19, 319.e1-3. PubMed ID: 19344719
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
[TBL] [Abstract][Full Text] [Related]
15. Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.
Cripps JG; Celaj S; Burdick M; Strieter RM; Gorham JD
Lab Invest; 2012 Oct; 92(10):1461-71. PubMed ID: 22906987
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1β induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration.
Guo YC; Chiu YH; Chen CP; Wang HS
Stem Cell Res Ther; 2018 Oct; 9(1):281. PubMed ID: 30359318
[TBL] [Abstract][Full Text] [Related]
17. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.
Dangaj D; Bruand M; Grimm AJ; Ronet C; Barras D; Duttagupta PA; Lanitis E; Duraiswamy J; Tanyi JL; Benencia F; Conejo-Garcia J; Ramay HR; Montone KT; Powell DJ; Gimotty PA; Facciabene A; Jackson DG; Weber JS; Rodig SJ; Hodi SF; Kandalaft LE; Irving M; Zhang L; Foukas P; Rusakiewicz S; Delorenzi M; Coukos G
Cancer Cell; 2019 Jun; 35(6):885-900.e10. PubMed ID: 31185212
[TBL] [Abstract][Full Text] [Related]
18. CXCR3-mediated skin homing of autoreactive CD8 T cells is a key determinant in murine graft-versus-host disease.
Villarroel VA; Okiyama N; Tsuji G; Linton JT; Katz SI
J Invest Dermatol; 2014 Jun; 134(6):1552-1560. PubMed ID: 24390137
[TBL] [Abstract][Full Text] [Related]
19. CXCL9 causes heterologous desensitization of CXCL12-mediated memory T lymphocyte activation.
Giegold O; Ogrissek N; Richter C; Schröder M; Herrero San Juan M; Pfeilschifter JM; Radeke HH
J Immunol; 2013 Apr; 190(7):3696-705. PubMed ID: 23447686
[TBL] [Abstract][Full Text] [Related]
20. Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice.
Yano T; Ohira M; Nakano R; Tanaka Y; Ohdan H
PLoS One; 2017; 12(10):e0186997. PubMed ID: 29088306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
